Skip to main content
OpenTrials
Completed

NCT Number: NCT02612493

Obesity and Metabolic Surgery in Patients With Type I Diabetes

Obesity is the indication for bariatric surgery in type I diabetes. Interestingly postsurgery the patients improve remarkable in their need for insulin, not only in the daily total insulin dosage but also in the dosage of IU per kg.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The investigators performed a retrospective analysis on 16 patients undergoing weight loss surgery in obesity with concomitant type I diabetes. All patients were evaluated during Follow - Up to analyze insulin dosage and metabolic changes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • type I diabetes
  • BMI > 40kg/m2

Exclusion criteria

  • type II diabetes

Treatment and study plan

Obese patients with type I diabetes

Other

Postsurgical follow - up in obese patients with type I diabetes

Primary outcomes

  1. Insulin dosage

    Time frame: up to 8 years

    Insulin dosage postsurgery

Secondary outcomes

  1. Excess Weight loss in %

    Time frame: up to 8 years

  2. Change in HgA1c

    Time frame: up to 8 years

  3. Change in lipids

    Time frame: up to 8 years

Sponsors and collaborators

Lead sponsor

Sana Klinikum Offenbach

Other

Registry information

Important dates

Study start
2006
Primary completion
2015
Study completion
2015
First posted
Nov 23, 2015
Registry last updated
Nov 23, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.